Sarcomatoid renal cell carcinoma typically signifies an exceptionally poor prognosis, with patients rarely surviving beyond one year. An 83-year-old male presented to our hospital with complaints of headache and left-sided limb weakness. Computed tomography (CT) scans of the head and lungs disclosed a mass within the right temporal lobe, accompanied by peritumoral edema in the right cerebral hemisphere. Brain magnetic resonance imaging (MRI) with contrast enhancement and diffusion-weighted imaging (DWI) delineated a mass in the right temporal lobe, measuring 3 × 3 × 3 cm. He underwent cytoreductive surgery successively in the neurosurgery and urology departments. Despite experiencing postoperative tumour recurrence, the patient has lived close to four years to date. This case report illustrates that cytoreductive surgery combined with systemic pharmacotherapy can still confer significant survival benefits for elderly patients.
Keyphrases
- contrast enhanced
- diffusion weighted imaging
- magnetic resonance imaging
- computed tomography
- poor prognosis
- diffusion weighted
- case report
- magnetic resonance
- minimally invasive
- long non coding rna
- coronary artery bypass
- renal cell carcinoma
- dual energy
- positron emission tomography
- end stage renal disease
- resting state
- white matter
- newly diagnosed
- cerebral ischemia
- patients undergoing
- free survival
- healthcare
- ejection fraction
- image quality
- percutaneous coronary intervention
- acute coronary syndrome
- emergency department
- subarachnoid hemorrhage
- coronary artery disease
- prognostic factors
- functional connectivity
- metastatic renal cell carcinoma